Abstract | BACKGROUND: PATIENTS AND METHODS: Preoperative serum samples were acquired from 80 patients and healthy volunteers who served as normal controls. VEGF-C levels were assessed using enzyme-linked immunosorbent assay (ELISA). RESULTS: The preoperative serum VEGF-C level in patients with esophageal cancer was significantly higher than in healthy volunteers. Furthermore, patients with recurrence had significantly higher preoperative serum VEGF-C levels than patients without recurrence, and a high preoperative serum VEGF-C level was found to be an independent risk factor for recurrence, in addition to lymph node metastasis. CONCLUSION:
|
Authors | Hitoshi Kimura, Hiroyuki Kato, Naritaka Tanaka, Takanori Inose, Ahmad Faried, Makoto Sohda, Masanobu Nakajima, Yasuyuki Fukai, Tatsuya Miyazaki, Norihiro Masuda, Ryokuhei Manda, Minoru Fukuchi, Hitoshi Ojima, Katsuhiko Tsukada, Hiroyuki Kuwano |
Journal | Anticancer research
(Anticancer Res)
2008 Jan-Feb
Vol. 28
Issue 1A
Pg. 165-9
ISSN: 0250-7005 [Print] Greece |
PMID | 18383841
(Publication Type: Journal Article)
|
Chemical References |
- Vascular Endothelial Growth Factor C
|
Topics |
- Enzyme-Linked Immunosorbent Assay
- Esophageal Neoplasms
(blood, blood supply, pathology, surgery)
- Female
- Humans
- Lymphatic Metastasis
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(blood, pathology)
- Predictive Value of Tests
- Preoperative Care
- Sensitivity and Specificity
- Vascular Endothelial Growth Factor C
(blood)
|